Janus Health is changing the way the healthcare revenue cycle functions. Billions of dollars are left uncollected due to poor processes and inconsistent human decision making. Janus studies end-user behavior within the revenue cycle and determines the optimal path for each process. Real-time predictive recommendations are made to human workers to guide them on the next best action to perform with every claim. Janus also automates steps in a process or end-to-end workflows using a proprietary platform that is highly scalable and modular. Managers and executives receive actionable insights into people, productivity and processes, allowing them to optimally allocate and manage resources.
Generate more cash yield, accelerate receivables and reduce the cost-to-collect with Janus.
Generate more cash yield, accelerate receivables and reduce the cost-to-collect with Janus.
Location: United States, Illinois, Chicago
Employees: 51-200
Total raised: $8M
Founded date: 2020
Investors 2
| Date | Name | Website |
| - | Caduceus C... | caduceus.v... |
| 08.04.2023 | Enhanced H... | enhancedhe... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.12.2021 | Series A | $8M | - |
Mentions in press and media 5
| Date | Title | Description |
| 21.03.2023 | Enhanced Healthcare Partners Announces Growth Investment In Healthcare RCM Technology Platform Janus | Salt Lake City, UT (March 21, 2023) — Enhanced Healthcare Partners (“EHP”), a leading private equity firm specializing in transformative, middle-market healthcare businesses, announced today a strategic growth investment in Janus, a leading... |
| 21.03.2023 | Janus Receives Growth Investment from Enhanced Healthcare Partners | Janus, a Chicago, IL-based provider of healthcare revenue cycle management (RCM) technology, received a strategic growth investment from Enhanced Healthcare Partners (EHP). The company intends to use for rapid market expansion, product deve... |
| 24.12.2021 | StartUPDATES: New developments for healthcare startups | DermBiont, a clinical stage biotechnology company developing targeted topical therapeutics that address the root causes of skin diseases, has raised a $28 million Series A2 financing. It has also acquired clinical-stage biotechnology compan... |
| - | StartUPDATES: New developments for healthcare startups | DermBiont, a clinical stage biotechnology company developing targeted topical therapeutics that address the root causes of skin diseases, has raised a $28 million Series A2 financing. It has also acquired clinical-stage biotechnology compan... |
| - | Janus Health Technologies | “Janus' platform is designed to help solve today's most challenging healthcare revenue cycle problems so that you can focus on patient care.” |